Skip to content
ppharmaranks
Menu

Best treatments for stomach neoplasms

5 products may treat stomach neoplasms, spanning FDA drug classes such as her2/neu receptor antagonist, alkylating drug. The current highest-rated option is herceptin. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 5 drugs we list for stomach neoplasms, none are yet flagged as generics in our price data, spanning classes such as her2/neu receptor antagonist, alkylating drug. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for stomach neoplasms — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 18, 2026·How we rate

Top-rated picks for stomach neoplasms: 1. Herceptin · 2. Hercessi · 3. Mitomycin

Top-rated treatments for stomach neoplasms, ranked by pharmaranks score
#DrugRatingPharmacy pays
170/100View →
270/100View →
3Not yet ratedView →
4Not yet ratedView →
5Not yet ratedView →

Full ranking · 5 treatments

Frequently asked

What treats stomach neoplasms?
Our catalog lists 5 products that may treat stomach neoplasms, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is herceptin.
What is the best-rated treatment for stomach neoplasms?
By our independent recall-safety rating — not an efficacy measure — herceptin ranks highest among the products we list for stomach neoplasms. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat stomach neoplasms?
Treatments for stomach neoplasms span FDA drug classes including her2/neu receptor antagonist, alkylating drug. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.